Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Xiayang Qiu

Showing results (21-30 of 36) with videos related to

Pageof 4
Sort By:
Nature Communications|December 5, 2017
Lysosomal integral membrane protein-2 as a phospholipid receptor revealed by biophysical and cellular studiesKaren S Conrad, Ting-Wen Cheng, Daniel Ysselstein, et al.
The Journal of Biological Chemistry|January 12, 2010
SRT1720, SRT2183, SRT1460, and resveratrol are not direct activators of SIRT1Michelle Pacholec, John E Bleasdale, Boris Chrunyk, et al.
The Journal of Biological Chemistry|April 28, 2006
Crystal structure of the herpes simplex virus 1 DNA polymeraseShenping Liu, John D Knafels, Jeanne S Chang, et al.
Nature Communications|March 30, 2020
Synthetic antibodies against BRIL as universal fiducial marks for single-particle cryoEM structure determination of membrane proteinsSomnath Mukherjee, Satchal K Erramilli, Mark Ammirati, et al.
Bioorganic & Medicinal Chemistry Letters|March 12, 2009
(3,3-Difluoro-pyrrolidin-1-yl)-[(2S,4S)-(4-(4-pyrimidin-2-yl-piperazin-1-yl)-pyrrolidin-2-yl]-methanone: a potent, selective, orally active dipeptidyl peptidase IV inhibitorMark J Ammirati, Kim M Andrews, David D Boyer, et al.
Nature Structural & Molecular Biology|April 17, 2007
Structural and biophysical studies of PCSK9 and its mutants linked to familial hypercholesterolemiaDavid Cunningham, Dennis E Danley, Kieran F Geoghegan, et al.
Science Translational Medicine|April 6, 2023
Rational design of a highly immunogenic prefusion-stabilized F glycoprotein antigen for a respiratory syncytial virus vaccineYe Che, Alexey V Gribenko, Xi Song, et al.
Scientific Reports|May 18, 2016
Inhibiting complex IL-17A and IL-17RA interactions with a linear peptideShenping Liu, Joel Desharnais, Parag V Sahasrabudhe, et al.
Journal of Medicinal Chemistry|April 18, 2003
Indole naphthyridinones as inhibitors of bacterial enoyl-ACP reductases FabI and FabKMark A Seefeld, William H Miller, Kenneth A Newlander, et al.
Journal of Medicinal Chemistry|July 12, 2002
Discovery of aminopyridine-based inhibitors of bacterial enoyl-ACP reductase (FabI)William H Miller, Mark A Seefeld, Kenneth A Newlander, et al.
Pageof 4

Showing results (21-30 of 36) with videos related to

Sort By:
Pageof 4
Nature Communications|December 5, 2017
Lysosomal integral membrane protein-2 as a phospholipid receptor revealed by biophysical and cellular studiesKaren S Conrad, Ting-Wen Cheng, Daniel Ysselstein, et al.
The Journal of Biological Chemistry|January 12, 2010
SRT1720, SRT2183, SRT1460, and resveratrol are not direct activators of SIRT1Michelle Pacholec, John E Bleasdale, Boris Chrunyk, et al.
The Journal of Biological Chemistry|April 28, 2006
Crystal structure of the herpes simplex virus 1 DNA polymeraseShenping Liu, John D Knafels, Jeanne S Chang, et al.
Nature Communications|March 30, 2020
Synthetic antibodies against BRIL as universal fiducial marks for single-particle cryoEM structure determination of membrane proteinsSomnath Mukherjee, Satchal K Erramilli, Mark Ammirati, et al.
Bioorganic & Medicinal Chemistry Letters|March 12, 2009
(3,3-Difluoro-pyrrolidin-1-yl)-[(2S,4S)-(4-(4-pyrimidin-2-yl-piperazin-1-yl)-pyrrolidin-2-yl]-methanone: a potent, selective, orally active dipeptidyl peptidase IV inhibitorMark J Ammirati, Kim M Andrews, David D Boyer, et al.
Nature Structural & Molecular Biology|April 17, 2007
Structural and biophysical studies of PCSK9 and its mutants linked to familial hypercholesterolemiaDavid Cunningham, Dennis E Danley, Kieran F Geoghegan, et al.
Science Translational Medicine|April 6, 2023
Rational design of a highly immunogenic prefusion-stabilized F glycoprotein antigen for a respiratory syncytial virus vaccineYe Che, Alexey V Gribenko, Xi Song, et al.
Scientific Reports|May 18, 2016
Inhibiting complex IL-17A and IL-17RA interactions with a linear peptideShenping Liu, Joel Desharnais, Parag V Sahasrabudhe, et al.
Journal of Medicinal Chemistry|April 18, 2003
Indole naphthyridinones as inhibitors of bacterial enoyl-ACP reductases FabI and FabKMark A Seefeld, William H Miller, Kenneth A Newlander, et al.
Journal of Medicinal Chemistry|July 12, 2002
Discovery of aminopyridine-based inhibitors of bacterial enoyl-ACP reductase (FabI)William H Miller, Mark A Seefeld, Kenneth A Newlander, et al.
Pageof 4